Cited by

• Clinical research methodology process: what has changed with COVID-19?

  Tavazzi L. Tavazzi L. Eur Heart J Suppl. 2022 Nov 12;24(Suppl I):I175-I180. doi: 10.1093/eurheartjsupp/suac090. eCollection 2022 Nov. Eur Heart J Suppl. 2022. PMID: 36380784 Free PMC article.
• Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making.

  Bakker E, Plueschke K, Jonker CJ, Kurz X, Starokozhko V, Mol PGM. Bakker E, et al. Clin Pharmacol Ther. 2023 Jan;113(1):135-151. doi: 10.1002/cpt.2766. Epub 2022 Nov 4. Clin Pharmacol Ther. 2023. PMID: 36254408 Free PMC article.
• Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study.

  Iacovino ML, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, Salerno F, Olimpieri PP, Di Segni S, Sferrazza A, Piccirillo MC, Beretta GD, Pinto C, Blasi L, Cinieri S, Cavanna L, Di Maio M, Russo P, Perrone F. Iacovino ML, et al. Lancet Reg Health Eur. 2024 Apr 22;41:100912. doi: 10.1016/j.lanepe.2024.100912. eCollection 2024 Jun. Lancet Reg Health Eur. 2024. PMID: 38665620 Free PMC article.
• The real world of acute lymphoblastic leukemia.

  Litzow MR. Litzow MR. Haematologica. 2025 Jan 1;110(1):20-21. doi: 10.3324/haematol.2024.286346. Haematologica. 2025. PMID: 39234859 Free PMC article. No abstract available.
• Pharmacovigilance in Cell and Gene Therapy: Evolving Challenges in Risk Management and Long-Term Follow-Up.

  Youssef E, Weddle K, Zimmerman L, Palmer D. Youssef E, et al. Drug Saf. 2025 Aug 9. doi: 10.1007/s40264-025-01596-9. Online ahead of print. Drug Saf. 2025. PMID: 40783602 Review.